Min Luo

Title: Min Luo - Innovator in Immunotherapy

Introduction

Min Luo is a prominent inventor based in Irving, TX (US). He has made significant contributions to the field of immunotherapy through his innovative research and patent developments. His work focuses on creating advanced vaccine compositions that can enhance the body's immune response.

Latest Patents

Min Luo holds a patent for a "Sting activating nanovaccine for immunotherapy." This patent describes vaccine compositions that include an antigen and a diblock copolymer, which is responsive to pH levels. The compositions are designed to activate the STING and/or interferon receptor pathways, providing a novel approach to treating infectious diseases and cancer. The diblock copolymer is engineered to achieve a pKa ranging from about 6 to about 7.5, enhancing its effectiveness in therapeutic applications.

Career Highlights

Min Luo is affiliated with the University of Texas System, where he conducts his research and development. His work has garnered attention for its potential to revolutionize immunotherapy and improve treatment outcomes for patients suffering from various diseases.

Collaborations

Min Luo collaborates with esteemed colleagues, including Jinming Gao and Zhijian Chen. Their combined expertise contributes to the advancement of innovative solutions in the field of immunotherapy.

Conclusion

Min Luo's contributions to immunotherapy through his patented innovations highlight his role as a leading inventor in the field. His work promises to pave the way for new treatment options that could significantly impact patient care.